{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:07:54Z","timestamp":1792213674531,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2014.06.070","type":"journal-article","created":{"date-parts":[[2014,6,22]],"date-time":"2014-06-22T08:15:17Z","timestamp":1403424917000},"page":"2727-2733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Lasting immune memory against hepatitis B following challenge 10\u201311 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV\/Hib or monovalent hepatitis B vaccine at 3, 5 and 11\u201312 months of age"],"prefix":"10.1016","volume":"33","author":[{"given":"M\u00e1ria","family":"Avdicova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya D.","family":"Crasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.06.070_bib0005","first-page":"405","article-title":"Hepatitis B vaccines","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0010","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0015","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/clinids\/20.4.992","article-title":"Risks of chronicity following acute hepatitis B virus infection: a review","volume":"20","author":"Hyams","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jama.1995.03530150025029","article-title":"Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations","volume":"274","author":"Margolis","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0025","first-page":"443","article-title":"Progress in the control of viral hepatitis: memorandum from a WHO meeting","volume":"66","year":"1988","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0030","series-title":"Prevention and control of perinatal hepatitis B virus (HBV) transmission in the WHO European region \u2013 a VHPB Symposium Report","author":"Viral Hepatitis Prevention Board (VHPB)","year":"2006"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/erv.09.32","article-title":"Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV\/Hib hexavalent vaccine)","volume":"8","author":"Zepp","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0040","unstructured":"National Childhood Vaccination Schedules. Available at http:\/\/www.euvac.net\/graphics\/euvac\/vaccination\/vaccination.html [accessed 23.06.14]."},{"key":"10.1016\/j.vaccine.2014.06.070_bib0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/INF.0b013e31805d7f17","article-title":"Use of combination vaccines is associated with improved coverage rates","volume":"26","author":"Marshall","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","article-title":"The use of combination vaccines has improved timeliness of vaccination in children","volume":"25","author":"Kalies","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0055","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.vaccine.2012.02.024","article-title":"Immunogenicity of InfanrixTM hexa administered at 3, 5 and 11 months of age","volume":"30","author":"Van Der Meeren","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0060","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00431-002-1079-5","article-title":"Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV\/Hib vaccine compared to separate concomitant injections of DTPa-IPV\/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule","volume":"161","author":"Avdicov\u00e1","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0065","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4161\/hv.9051","article-title":"Immune memory to hepatitis B virus in 4\u20139-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV\/Hib vaccine","volume":"5","author":"Zinke","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0070","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.vaccine.2006.09.060","volume":"25","author":"Heininger","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2334-10-9","article-title":"Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV\/Hib in the first and 2nd year of life","volume":"10","author":"Steiner","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tmaid.2006.04.004","article-title":"A review of the long-term protection after hepatitis A and B vaccination","volume":"5","author":"Van Damme","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","article-title":"Are booster immunisations needed for lifelong hepatitis B immunity?","volume":"355","author":"European Consensus Group on Hepatitis B Immunity","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0090","series-title":"Core information for the development of immunization policy","author":"World Health Organisation","year":"2002"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2334-8-100","article-title":"A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines","volume":"8","author":"Giambi","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0100","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1473-3099(10)70195-X","article-title":"Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study","volume":"10","author":"Zanetti","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0105","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.vaccine.2005.03.017","article-title":"Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants","volume":"23","author":"Fitzsimons","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0110","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1542\/peds.2007-0131","article-title":"Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy","volume":"120","author":"Samandari","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0115","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.vaccine.2009.10.074","article-title":"Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand","volume":"28","author":"Poovorawan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0120","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1016\/j.vaccine.2007.09.013","article-title":"Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination","volume":"25","author":"Su","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.inf.0000154329.00361.39","article-title":"Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country","volume":"24","author":"Duval","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.06.070_bib0130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3748\/wjg.v10.i2.260","article-title":"Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination","volume":"10","author":"Wang","year":"2004","journal-title":"World J Gastroenterol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T20:20:08Z","timestamp":1565554808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14008718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":26,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X14008718"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lasting immune memory against hepatitis B following challenge 10\u201311 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV\/Hib or monovalent hepatitis B vaccine at 3, 5 and 11\u201312 months of age","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}